XML 35 R15.htm IDEA: XBRL DOCUMENT
v3.19.2

Stockholders' Equity | 12 Months Ended
--- | ---
Jun. 29, 2019
Equity [Abstract] |
Stockholders' Equity |
8. | Stockholders’ Equity
Preferred Stock We are authorized, subject to limitations imposed by Delaware law, to issue up to a total of 10,000,000 shares of preferred stock in one or more series without stockholder approval. Our Board of Directors has the power to establish, from time to time, the number of shares to be included in each series and to fix the rights, preferences, and privileges of the shares of each wholly unissued series and any of its qualifications, limitations, or restrictions. Our Board of Directors can also increase or decrease the number of shares of a series, but not below the number of shares of that series then outstanding, without any further vote or action by the stockholders. Our Board of Directors may authorize the issuance of preferred stock with voting or conversion rights that could harm the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of our company and might harm the market price of our common stock and the voting power and other rights of the holders of our common stock. As of the end of fiscal 2019, there were no shares of preferred stock outstanding. Shares Reserved for Future Issuance Shares of common stock reserved for future issuance as of the end of fiscal 2019 were as follows:
Stock options outstanding |  |  | 1,191,929 |
Deferred stock units outstanding |  |  | 1,878,853 |
Market stock units outstanding |  |  | 210,732 |
Performance stock units outstanding |  |  | 192,618 |
Awards available for grant under all share-based compensation plans |  |  | 2,891,466 |
Reserved for future issuance |  |  | 6,365,598 |
Treasury Stock Our cumulative authorization for our common stock repurchase program as of the end of fiscal 2019 is $1.3 billion, which was set to expire in July 2019. The program authorizes us to repurchase our common stock in the open market or in privately negotiated transactions depending upon market conditions and other factors. The number of shares repurchased and the timing of repurchases is based on the level of our cash balances, general business and market conditions, and other factors, including alternative investment opportunities. Common stock repurchased under this program is held as treasury stock. As of the end of fiscal 2019, we had $107.6 million remaining under our common stock repurchase program. In August 2019, our Board of Directors authorized the purchase of up to an additional $100.0 million of our common stock and extended the stock repurchase program through July 2021.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration